background. increased levels of albuminuria have been recognized as a feature of obesity and the metabolic syndrome, and to be associated with an increased risk for cardiovascular and renal disease.
蛋白尿水平的增加已作为是肥胖病和代谢综合征的一个特征而被人们认识,并与心血管疾病和肾脏疾病的发生风险相关联。
compare the change of hematuria, albuminuria and symptoms before and after treatment.
观察治疗前后患者血尿、蛋白尿及临床癥状的变化。
but our patients have very low albuminuria baseline and many of them will never develop diabetic nephropathy.
我们患者的基线白蛋白尿水平本来就很低,他们中的很多人根本就不会发生糖尿病肾病。
diabetic nephropathy, responsible for more than 45% of cases of end-stage renal disease in the united states, may be structurally advanced once albuminuria becomes detectable.
糖尿病肾病在美国是愈45%终末期肾病的病因,当有肾脏病理改变时可检测到白蛋白尿。
the results implied that low-grade albuminuria might be an early marker for the detection of cardiovascular disease in type 2 diabetic patients.
研究结果提示,低水平蛋白尿或许是检测2型糖尿病患者心血管疾病的一个早期标志物。
however, there was no significant association between albuminuria and hf in patients taking antihypertensive treatment.
然而,在接受抗高血压药物治疗的患者中,蛋白尿和hf没有显着相关性。
however, the link between early albuminuria and adiposity remains unclear.
然而,最初的蛋白尿和肥胖癥之间的联系仍不清楚。
albuminuria does not occur as this filtered albumin load is avidly bound and retrieved by ptcs.
如果这些滤过的白蛋白被近曲小管细胞充分地结合并摄取,则不会发生白蛋白尿。
the drug is approved for treatment of hypertension but has also shown renoprotective potential in patients with type 2 diabetes and albuminuria (4,5).
该药被批準用于治疗高血压,但也显示出在2型糖尿病和蛋白尿患者可能的肾脏保护作用(4,5)。
objective:to observe the therapeutic effect on glomerulus albuminuria treated by yishen fluid.
目的:观察益肾液治疗肾小球性蛋白尿的疗效。
the curative effect on syndrome, albuminuria and hematuria were observed.
观察证候疗效、蛋白尿和血尿疗效。
interestingly, the word proteinuria was introduced later, but the words albuminuria and proteinuria hae often been used interchangeably—which clearly they are not.
有趣的是,随后蛋白尿这一术语又被派生出来,虽然白蛋白尿和蛋白尿这两个术语常常被交替使用,但很明显两者并不等同。
concluson:rosiglitazone has significant curative effect on diabetes, it can also delay the occurrence of albuminuria and significantly lighten pathological changes of renal glomerulus.
结论:罗格列酮对糖尿病不仅有明显的治疗作用,而且可延缓蛋白尿的发生,明显减轻肾小球的病理改变。
objective to investigate the effects of the combination of low molecular weight heparin and acei on albuminuria in diabetic nephropathy.
目的观察低分子肝素联合血管转换酶抑制剂对糖尿病肾病显性蛋白尿的治疗效果。
albuminuria is the best available surrogate parameter in the treatment of diabetic nephropathy.
蛋白尿是糖尿病肾病治疗最好用的代表参数。
interestingly, the word proteinuria was introduced later, but the words albuminuria and proteinuria have often been used interchangeably—which clearly they are not.
有趣的是,随后蛋白尿这一术语又被派生出来,虽然白蛋白尿和蛋白尿这两个术语常常被交替使用,但很明显两者并不等同。